Oculis (OCS) Institutional Ownership $18.27 +0.67 (+3.84%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Oculis (NASDAQ:OCS)CurrentInstitutional OwnershipPercentage22.30%Number ofInstitutional Buyers(last 12 months)11TotalInstitutional Inflows(last 12 months)$28.43MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$3.60M Get OCS Insider Trade Alerts Want to know when executives and insiders are buying or selling Oculis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OCS Institutional Buying and Selling by Quarter Oculis Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Alyeska Investment Group L.P.131,332$2.50M0.0%N/A0.301% 5/14/2025 Pivotal bioVenture Partners Investment Advisor LLC2,300,774$43.78M35.4%+32.4%5.270% 5/13/2025 SR One Capital Management LP322,500$6.14M1.6%N/A0.739% 5/13/2025 Aberdeen Group plc1,253,119$23.85M0.0%+24.1%2.870% 5/5/2025 Kestra Private Wealth Services LLC12,322$234K0.0%N/A0.028% 4/16/2025 Compagnie Lombard Odier SCmA87,000$1.66M0.0%-9.1%0.199% 2/17/2025 Citadel Advisors LLC22,911$389K0.0%N/A0.057% 2/17/2025 Bank of America Corp DE28,980$493K0.0%+58.2%0.072% 2/17/2025 Bellevue Group AG10,000$170K0.0%N/A0.025% 2/13/2025 XTX Topco Ltd13,249$225K0.0%N/A0.033% 2/12/2025 Geode Capital Management LLC16,744$284K0.0%+12.0%0.041% 1/24/2025 abrdn plc1,009,424$17.15M0.0%+23.0%2.492% 10/25/2024 abrdn plc820,553$10.06M0.0%-25.4%2.026% 5/14/2024 Nan Fung Group Holdings Ltd436,378$5.26M4.9%-15.9%1.077% 2/14/2024 Pivotal bioVenture Partners Investment Advisor LLC1,888,788$21.21M5.4%-14.9%5.190% 2/6/2024 Searle & CO.10,000$112K0.0%N/A0.027% 1/31/2024 abrdn plc1,452,741$15.98M0.0%N/A3.992% 1/16/2024 Compagnie Lombard Odier SCmA95,750$1.05M0.0%+47.3%0.263% 11/14/2023 Nan Fung Group Holdings Ltd606,684$6.67M5.4%-6.8%1.667% 11/14/2023 Pivotal bioVenture Partners Investment Advisor LLC2,218,754$24.41M9.7%-6.8%6.097% 11/13/2023 Wolverine Asset Management LLC7,021$77K0.0%N/A0.019% 9/21/2023 Barclays PLC3,602$44K0.0%N/A0.010% 5/12/2023 Nan Fung Group Holdings Ltd651,100$4.84M3.3%N/A1.989% 5/1/2023 Compagnie Lombard Odier SCmA65,000$472K0.0%N/A0.199% (Data available from 1/1/2016 forward) OCS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OCS shares? During the previous two years, 16 institutional investors and hedge funds held shares of Oculis. The most heavily invested institutionals were Pivotal bioVenture Partners Investment Advisor LLC ($43.78M), Aberdeen Group plc ($23.85M), abrdn plc ($17.15M), SR One Capital Management LP ($6.14M), Nan Fung Group Holdings Ltd ($5.26M), Alyeska Investment Group L.P. ($2.50M), and Compagnie Lombard Odier SCmA ($1.66M).Learn more on OCS's institutional investors. What percentage of Oculis stock is owned by institutional investors? 22.30% of Oculis stock is owned by institutional investors. Learn more on OCS's institutional investor holdings. Which institutional investors have been buying Oculis stock? Of the 15 institutional investors that purchased Oculis stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: abrdn plc ($1.64M), Pivotal bioVenture Partners Investment Advisor LLC ($563.08K), SR One Capital Management LP ($322.50K), Aberdeen Group plc ($243.70K), Alyeska Investment Group L.P. ($131.33K), Compagnie Lombard Odier SCmA ($30.75K), and Citadel Advisors LLC ($22.91K). How much institutional buying is happening at Oculis? Institutional investors have bought a total of 3,024,539 shares in the last 24 months. This purchase volume represents approximately $45.32M in transactions. Which Oculis major shareholders have been selling company stock? The following institutional investors have sold Oculis stock in the last 24 months: Pivotal bioVenture Partners Investment Advisor LLC ($492.41K), abrdn plc ($279.88K), Nan Fung Group Holdings Ltd ($126.97K), and Compagnie Lombard Odier SCmA ($8.75K). How much institutional selling is happening at Oculis? Institutional investors have sold a total of 908,008 shares in the last 24 months. This volume of shares sold represents approximately $10.57M in transactions. Related Companies MRUS Institutional Ownership ACAD Institutional Ownership CPRX Institutional Ownership MOR Institutional Ownership PTGX Institutional Ownership MTSR Institutional Ownership XENE Institutional Ownership MLTX Institutional Ownership IMVT Institutional Ownership HCM Institutional Ownership This page (NASDAQ:OCS) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Oculis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OCS Stock Free OCS Stock Alerts